New biomarkers may influence drug design and alternative treatments of cancer, study shows

Researchers have discovered gene-targets (biomarkers) that may enable alternative treatments or the potential design of new drugs that target metastasis-promoting tumor genes.

This is the key finding in a study led by researchers from Georgia State University in collaboration with the University of Oklahoma College of Medicine and published in journal Oncotarget.

The spread of cancer cells from the initial site of occurrence (primary site) to other secondary tissues is called metastasis, and contributes to poor or limited response of cancer cells to treatments, which results in death. For example, cancer cells initially in the lungs can begin to spread to other organs, including the brain and liver.

- Full Story - »»»    

UGA ecologist finds another cause of antibiotic resistance   Don’t Blame Breast Density; $$$ Toxicity; ‘Nurse Ratched’ Returns   Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy   Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy   Sex and violence may not really sell products   Anxiety increases the risk of gastrointestinal infection and long-term complications   Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar   New drug for neuroblastoma shows promise in phase I study   GPs and the Fit for Work scheme   Experimental treatment sends deadly leukemia into remission   Study could reduce unnecessary cancer screening   Study shows global warming is unlikely to reduce winter deaths